[
  {
    "ts": "2026-02-19T08:43:12+00:00",
    "headline": "BioNTech SE (BNTX) Rallying on Solid Oncology Strategy",
    "summary": "BioNTech SE (NASDAQ:BNTX) is one of the best stocks to buy and hold for the next 6 months. On February 2, research firm Leerink Partners downgraded BioNTech SE (NASDAQ:BNTX) to a Market Perform from an Outperform and set a $113 price target. The downgrade is in response to the stock rallying from its December lows […]",
    "url": "https://finance.yahoo.com/news/biontech-se-bntx-rallying-solid-084312260.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9a307ff9-2aaa-30ad-969b-11dec6add85f",
      "content": {
        "id": "9a307ff9-2aaa-30ad-969b-11dec6add85f",
        "contentType": "STORY",
        "title": "BioNTech SE (BNTX) Rallying on Solid Oncology Strategy",
        "description": "",
        "summary": "BioNTech SE (NASDAQ:BNTX) is one of the best stocks to buy and hold for the next 6 months. On February 2, research firm Leerink Partners downgraded BioNTech SE (NASDAQ:BNTX) to a Market Perform from an Outperform and set a $113 price target. The downgrade is in response to the stock rallying from its December lows […]",
        "pubDate": "2026-02-19T08:43:12Z",
        "displayTime": "2026-02-19T08:43:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f48549c2d66d1ffce22e4441a74a7d17",
          "originalWidth": 750,
          "originalHeight": 500,
          "caption": "BioNTech SE (BNTX) Rallying on Solid Oncology Strategy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IwDwP4NBBzqaDYqwt4Ki0Q--~B/aD01MDA7dz03NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f48549c2d66d1ffce22e4441a74a7d17.cf.webp",
              "width": 750,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/doTkQNaLwA513_fJKALYTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f48549c2d66d1ffce22e4441a74a7d17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biontech-se-bntx-rallying-solid-084312260.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biontech-se-bntx-rallying-solid-084312260.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BNTX"
            },
            {
              "symbol": "^SPSIBI"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T14:08:51+00:00",
    "headline": "Iberdomide Review And AI Alliance Add New Angles To BMY Outlook",
    "summary": "FDA accepts Bristol Myers Squibb's New Drug Application for iberdomide for relapsed or refractory multiple myeloma and grants Breakthrough Therapy Designation and Priority Review under Project Orbis. Bristol Myers Squibb joins an AI driven data sharing alliance with Evinova and other large pharmaceutical companies to support global clinical development. Both developments highlight progress in oncology research and digital drug development initiatives at Bristol Myers Squibb. For investors...",
    "url": "https://finance.yahoo.com/news/iberdomide-review-ai-alliance-add-140851952.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8b0220db-4741-3f0a-8ebb-332bdebfbda9",
      "content": {
        "id": "8b0220db-4741-3f0a-8ebb-332bdebfbda9",
        "contentType": "STORY",
        "title": "Iberdomide Review And AI Alliance Add New Angles To BMY Outlook",
        "description": "",
        "summary": "FDA accepts Bristol Myers Squibb's New Drug Application for iberdomide for relapsed or refractory multiple myeloma and grants Breakthrough Therapy Designation and Priority Review under Project Orbis. Bristol Myers Squibb joins an AI driven data sharing alliance with Evinova and other large pharmaceutical companies to support global clinical development. Both developments highlight progress in oncology research and digital drug development initiatives at Bristol Myers Squibb. For investors...",
        "pubDate": "2026-02-19T14:08:51Z",
        "displayTime": "2026-02-19T14:08:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iberdomide-review-ai-alliance-add-140851952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iberdomide-review-ai-alliance-add-140851952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]